India to Netherlands: Atenolol Export Trade Route
India has recorded 42 verified shipments of Atenolol exported to Netherlands, representing a combined trade value of $2.0M USD. This corridor is served by 10 active Indian exporters, with an average shipment value of $47.5K USD. The leading Indian exporter is IPCA LABORATORIES LIMITED, which accounts for 92% of total export value with 7 shipments worth $1.8M USD. On the buying side, NA is the largest importer in Netherlands with $1.9M USD in purchases. The top 3 suppliers — IPCA LABORATORIES LIMITED, IPCA LABORATORIES LIMITED , S KANT HEALTHCARE LIMITED — together control 97% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.

Route Intelligence Overview
The India to Netherlands Atenolol corridor is one of India's established pharmaceutical export routes, with 42 shipments documented worth a combined $2.0M USD. The route is dominated by IPCA LABORATORIES LIMITED, which alone accounts for roughly 92% of all export value, reflecting the consolidated nature of India's atenolol manufacturing sector.
Across 10 active suppliers, the average shipment value stands at $47.5K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (66%) and air (16%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during July–September, with an average transit time of 31 days port-to-port. The route has recorded an annual growth rate of 28.2%, placing it at rank #14 among India's top atenolol export destinations globally.
On the import side, key buyers of Indian atenolol in Netherlands include NA, Aurobindo Pharma B.V. , TO THE ORDER and 13 others. NA is the single largest importer with 9 shipments valued at $1.9M USD.
Route Characteristics
- Average transit31 days
- Peak seasonQ3
- Primary modeMulti-modal
- Top portNHAVA SHEVA SEA (INNSA1)
Market Position
- Global rank#14
- Annual growth+28.2%
- Demand growth+25.5%
- Regulatory ease66/100
Top 10 Indian Atenolol Exporters to Netherlands
Showing top 10 of 10 Indian suppliers exporting Atenolol to Netherlands, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | IPCA LABORATORIES LIMITED Avg $262.0K per shipment | 7 | $1.8M | 91.9% |
| 2 | IPCA LABORATORIES LIMITED Avg $11.0K per shipment | 7 | $77.3K | 3.9% |
| 3 | S KANT HEALTHCARE LIMITED Avg $3.7K per shipment | 6 | $22.5K | 1.1% |
| 4 | MEDOPHARM Avg $2.5K per shipment | 6 | $15.1K | 0.8% |
| 5 | INTAS PHARMACEUTICALS LTD Avg $6.3K per shipment | 2 | $12.6K | 0.6% |
| 6 | S K age Exports Avg $9.8K per shipment | 1 | $9.8K | 0.5% |
| 7 | S KANT HEALTHCARE LIMITED Avg $3.1K per shipment | 3 | $9.2K | 0.5% |
| 8 | S K age Exports Avg $4.3K per shipment | 2 | $8.5K | 0.4% |
| 9 | MEDOPHARM Avg $3.2K per shipment | 2 | $6.4K | 0.3% |
| 10 | RUCHA ENTERPRISES Avg $6 per shipment | 6 | $37 | 0.0% |
This table shows the top 10 of 10 Indian companies exporting atenolol to Netherlands, ranked by total trade value. The listed exporters are: IPCA LABORATORIES LIMITED, IPCA LABORATORIES LIMITED , S KANT HEALTHCARE LIMITED, MEDOPHARM, INTAS PHARMACEUTICALS LTD, S K age Exports , S KANT HEALTHCARE LIMITED , S K age Exports, MEDOPHARM , RUCHA ENTERPRISES. IPCA LABORATORIES LIMITED is the dominant supplier with 7 shipments worth $1.8M USD, giving it a 92% market share. The top 3 suppliers together account for 97% of the total trade value on this route.
Top 10 Atenolol Importers in Netherlands
Showing top 10 of 16 known buyers in Netherlands receiving Atenolol shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian atenolol in Netherlands include NA, Aurobindo Pharma B.V. , TO THE ORDER, TO THE ORDER , ACCORD HEALTHCARE B V, among 16 total buyers. The largest importer is NA, accounting for $1.9M USD across 9 shipments — representing 94% of all atenolol imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | NA | 9 | $1.9M | 93.6% |
| 2 | Aurobindo Pharma B.V. | 4 | $38.2K | 1.9% |
| 3 | TO THE ORDER | 8 | $31.0K | 1.6% |
| 4 | TO THE ORDER | 4 | $19.0K | 1.0% |
| 5 | ACCORD HEALTHCARE B V | 2 | $12.6K | 0.6% |
| 6 | IMRES B.V | 4 | $7.9K | 0.4% |
| 7 | THE MEDICAL EXPORT GROUP | 2 | $7.2K | 0.4% |
| 8 | AUROBINDO PHARMA B V | 1 | $5.5K | 0.3% |
| 9 | M/S. AMSTEL FARMA BV | 1 | $3.5K | 0.2% |
| 10 | M/S. DB SCHENKER LOGISTICS NETHERLA | 1 | $3.0K | 0.1% |
Showing top 10 of 16 Atenolol importers in Netherlands on this route.
Top 10 Atenolol Formulations Imported by Netherlands
Showing top 10 of 31 product formulations shipped on the India to Netherlands Atenolol route, ranked by trade value
Netherlands imports a wide range of atenolol formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — HARMLESS MEDICINES - ATENOLOL 50MG TABLETS — accounts for $927.7K USD across 2 shipments. There are 31 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | HARMLESS MEDICINES - ATENOLOL 50MG TABLETS | 2 | $927.7K | 46.5% |
| 2 | HARMLESS MEDICINES - ATENOLOL 25MG TABLETS | 2 | $548.1K | 27.5% |
| 3 | HARMLESS MEDICINES - ATENOLOL 100MG TABLETS | 1 | $339.4K | 17.0% |
| 4 | HARMLESS MEDICINES - Atenolol Aurobindo | 2 | $19.1K | 1.0% |
| 5 | HARMLESS MEDICINES-ATENOLOL TABLETS BP 5 | 3 | $15.8K | 0.8% |
| 6 | HARMLESS MEDICINES - Atenolol 50mg Tablets | 1 | $15.4K | 0.8% |
| 7 | HARMLESS MEDICINES - (Atenolol Tablets 5 | 1 | $13.2K | 0.7% |
| 8 | HARMLESS MEDICINE-ATENOLOL TABLETS BP 50 | 2 | $12.8K | 0.6% |
| 9 | HARMLESS MEDICINES - Atenolol 25mg Tablets | 1 | $12.1K | 0.6% |
| 10 | HARMLESS MEDICINES - Atenolol 100mg Tablets | 1 | $11.7K | 0.6% |
Showing top 10 of 31 Atenolol formulations imported by Netherlands on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Balanced freight mix — 66% sea for bulk, 16% air for urgent orders.
Top Ports of Origin
NHAVA SHEVA SEA (INNSA1) handles the highest volume with 9 shipments. Transit time averages 31 days by sea.
Market Dynamics
India's atenolol exports to Netherlands are driven primarily by a handful of large-scale manufacturers. IPCA LABORATORIES LIMITED with 7 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 10 active exporters signals a competitive but concentrated market — buyers in Netherlands benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — IPCA LABORATORIES LIMITED, IPCA LABORATORIES LIMITED , S KANT HEALTHCARE LIMITED — together account for 97% of total trade value on this route. The average shipment value of $47.5K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as harmless medicines - atenolol 25mg tablets and harmless medicines - atenolol 100mg tablets, suggesting that buyers in Netherlands tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, NA is the largest importer with 9 shipments worth $1.9M USD — representing 94% of all atenolol imports from India on this route. A total of 16 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $2.0M
- Avg. Shipment
- $47.5K
- Suppliers
- 10
- Buyers
- 16
- Transit (Sea)
- ~31 days
- Annual Growth
- +28.2%
Reverse Direction
Netherlands → India — Atenolol (Import)Other Atenolol Routes
Unlock the Full India to Netherlands Atenolol Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 42 shipments on this route.
Frequently Asked Questions — India to Netherlands Atenolol Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Atenolol to Netherlands?
The leading Indian exporters of Atenolol to Netherlands are IPCA LABORATORIES LIMITED, IPCA LABORATORIES LIMITED , S KANT HEALTHCARE LIMITED. IPCA LABORATORIES LIMITED holds the largest market share at approximately 92% of total trade value on this route.
Q What is the total value of Atenolol exports from India to Netherlands?
India exports Atenolol to Netherlands worth approximately $2.0M USD across 42 recorded shipments. The average value per shipment is $47.5K USD.
Q Which ports does India use to ship Atenolol to Netherlands?
The most active port of origin is NHAVA SHEVA SEA (INNSA1) with 9 shipments. Indian exporters primarily use a mix of sea and air freight for this route, with 66% of shipments going by sea and 16% by air.
Q How long does shipping take from India to Netherlands for Atenolol?
The average transit time for Atenolol shipments from India to Netherlands is approximately 31 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during July–September.
Q Is the India to Netherlands Atenolol trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 28.2% with demand growth tracking at 25.5%. The route is ranked #14 among India's top Atenolol export destinations globally.
Q How many suppliers are active on the India to Netherlands Atenolol route?
There are currently 10 active Indian suppliers exporting Atenolol to Netherlands. The market is moderately concentrated with IPCA LABORATORIES LIMITED accounting for 92% of total shipment value.
Q Who are the main importers of Atenolol from India in Netherlands?
The leading importers of Indian Atenolol in Netherlands include NA, Aurobindo Pharma B.V. , TO THE ORDER, TO THE ORDER , ACCORD HEALTHCARE B V. NA is the largest buyer with 9 shipments worth $1.9M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Netherlands export trade corridor identified from Indian Customs (DGFT) records for Atenolol.
- 2.Supplier/Buyer Matching: 10 Indian exporters and 16 importers in Netherlands matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 42 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
42 Verified Shipments
10 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists